India’s next pharma powerhouses
India’s pharma growth is increasingly being shaped not just by companies, but by…
Interviews
India is well on its path to strongly push back the perception battle of quality
As we mark International Clinical Trial Day today, Dr Seema Pai, President, ISCR explains to Viveka Roychowdhury why it is…
Even drug-resistant cancer targets can be tackled with the right design strategy
Your work leverages AI and machine learning to optimise CAR-T cell therapy. How does this approach fundamentally differ from…
A uniform pricing regime ignores the heterogeneity within the pharma sector
Dr Amit Kumar: How can policy frameworks better align commercial interests in the pharma sector with broader public health goals?…
